What is Texas Instruments Incorporated's earnings per share (EPS)?

Texas Instruments Incorporated (TXN) reported diluted earnings per share of $5.45 for fiscal year 2025. This represents a 4.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Texas Instruments Incorporated (TXN) Financials

TXN

Trailing 12 months to June 30, 2026

Revenue $19.5B +16.7% YoY

Net Income $6.1B +20.1% YoY

EPS (Diluted) $6.57 +20.1% YoY

Free Cash Flow $5.4B +256.3% YoY

Market Cap $268.3B as of Oct 5, 2026

Price / Sales 13.8x on $19.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings 44.3x on $6.1B net income, trailing 12 months to June 30, 2026

Price / Book 14.9x on $18.0B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 24, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TXN SEC filings page.

Texas Instruments Incorporated (TXN) reported $19.5B in revenue over the twelve months to Jun 30, 2026, up 16.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TXN FY2025 2026-10-03

Texas Instruments is recovering revenue and cash flow, but factory investment and debt have left returns and margins below FY2022.

The key shift is cash conversion: operating cash flow recovered to $7.2B in FY2025, while free cash flow reached only $2.6B, showing that accounting profits are not translating one-for-one into discretionary cash. Sustained reinvestment explains much of the gap: capital expenditures were $4.6B in FY2025 after $4.8B in FY2024, rather than weak cash collection alone.

The recovery did not restore the prior margin structure: gross margin was 57.0% in FY2025 versus 58.1% in FY2024. Operating margin was 34.1%, far below FY2022's 50.6%, indicating that costs remain heavier than at the earlier peak.

FY2025 dividends were $5.0B against free cash flow of $2.6B, so distributions exceeded internally generated cash. Debt-to-equity rose from 0.6x in FY2022 to 0.8x in FY2025, increasing the financing burden as the company invests.

Financial Health Signals

Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Texas Instruments Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Texas Instruments Incorporated has an operating margin of 34.1%, meaning the company retains $34 of operating profit per $100 of revenue. This strong profitability earns a score of 92/100, reflecting efficient cost management and pricing power. This is down from 34.9% the prior year.

Growth

Texas Instruments Incorporated's revenue grew 13.0% year-over-year to $17.7B, a solid pace of expansion. This earns a growth score of 32/100.

Leverage

Texas Instruments Incorporated has a moderate D/E ratio of 0.83. This balance of debt and equity financing earns a leverage score of 42/100.

Liquidity

With a current ratio of 4.35, Texas Instruments Incorporated holds $4.35 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 89/100.

Cash Flow

Texas Instruments Incorporated converts 14.7% of revenue into free cash flow ($2.6B). This strong cash generation earns a score of 70/100.

Returns

Texas Instruments Incorporated earns a strong 30.7% return on equity (ROE), meaning it generates $31 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 81/100. This is up from 28.4% the prior year.

Altman Z-Score Safe

12.36

Texas Instruments Incorporated scores 12.36, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($268.3B) relative to total liabilities ($18.3B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Texas Instruments Incorporated passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.43x

For every $1 of reported earnings, Texas Instruments Incorporated generates $1.43 in operating cash flow ($7.2B OCF vs $5.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

11.09x

Texas Instruments Incorporated earns $11.09 in operating income for every $1 of interest expense ($6.0B vs $543.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.5B

YoY+22.8%

QoQ+13.2%

5Y CAGR+3.6%

10Y CAGR+5.3%

Texas Instruments Incorporated generated $5.5B in revenue in Q2 2026. This represents an increase of 22.8% from the same quarter a year earlier. Against the prior quarter it is up 13.2%.

EBITDA

$2.9B

YoY+41.2%

QoQ+21.6%

5Y CAGR+3.2%

10Y CAGR+7.7%

Texas Instruments Incorporated's EBITDA was $2.9B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 41.2% from the same quarter a year earlier. Against the prior quarter it is up 21.6%.

Net Income

$2.0B

YoY+52.9%

QoQ+28.2%

5Y CAGR+0.5%

10Y CAGR+9.2%

Texas Instruments Incorporated reported $2.0B in net income in Q2 2026. This represents an increase of 52.9% from the same quarter a year earlier. Against the prior quarter it is up 28.2%.

EPS (Diluted)

$2.14

YoY+51.8%

QoQ+27.4%

5Y CAGR+0.9%

10Y CAGR+10.5%

Texas Instruments Incorporated earned $2.14 per diluted share (EPS) in Q2 2026. This represents an increase of 51.8% from the same quarter a year earlier. Against the prior quarter it is up 27.4%.

Cash & Balance Sheet

Free Cash Flow

$2.2B

YoY+294.4%

QoQ+159.4%

5Y CAGR+4.8%

10Y CAGR+8.7%

Texas Instruments Incorporated generated $2.2B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 294.4% from the same quarter a year earlier. Against the prior quarter it is up 159.4%.

Cash & Debt

$3.7B

YoY+20.2%

QoQ+3.1%

5Y CAGR+0.1%

10Y CAGR+11.5%

Texas Instruments Incorporated held $3.7B in cash against $12.9B in long-term debt as of Q2 2026.

Dividends Per Share

$1.42

YoY+4.4%

QoQ0.0%

Texas Instruments Incorporated paid $1.42 per share in dividends in Q2 2026. This represents an increase of 4.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

913M

YoY+0.5%

QoQ+0.3%

5Y CAGR-0.2%

10Y CAGR-0.9%

Texas Instruments Incorporated had 913M shares outstanding in Q2 2026. This represents an increase of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Margins & Returns

Gross Margin

61.4%

YoY+3.5pp

QoQ+3.4pp

5Y change-5.8pp

10Y change0.0pp

Texas Instruments Incorporated's gross margin was 61.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.

Operating Margin

42.3%

YoY+7.1pp

QoQ+4.8pp

5Y change-6.0pp

10Y change+7.7pp

Texas Instruments Incorporated's operating margin was 42.3% in Q2 2026, reflecting core business profitability. This is up 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.8 percentage points.

Net Margin

36.2%

YoY+7.1pp

QoQ+4.2pp

5Y change-5.9pp

10Y change+11.2pp

Texas Instruments Incorporated's net profit margin was 36.2% in Q2 2026, showing the share of revenue converted to profit. This is up 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.2 percentage points.

Return on Equity

11.0%

YoY+3.1pp

QoQ+1.8pp

5Y change-6.3pp

10Y change+2.8pp

Texas Instruments Incorporated's ROE was 11.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Capital Allocation

R&D Spending

$535.0M

YoY+1.5%

QoQ+4.9%

5Y CAGR+6.5%

Texas Instruments Incorporated invested $535.0M in research and development in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 4.9%.

Share Buybacks

$27.0M

YoY-91.1%

QoQ-82.9%

5Y CAGR-28.6%

10Y CAGR-25.7%

Texas Instruments Incorporated spent $27.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 91.1% from the same quarter a year earlier. Against the prior quarter it is down 82.9%.

Capital Expenditures

$514.0M

YoY-60.6%

QoQ-24.0%

5Y CAGR+5.9%

10Y CAGR+12.5%

Texas Instruments Incorporated invested $514.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 60.6% from the same quarter a year earlier. Against the prior quarter it is down 24.0%.

TXN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TXN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$19.5B	$17.7B+13.0%	$15.6B-10.7%	$17.5B-12.5%	$20.0B+9.2%	$18.3B+26.9%	$14.5B+0.5%	$14.4B-8.9%	$15.8B+5.5%	$15.0B+11.9%	$13.4B+2.8%	$13.0B-0.3%	$13.0B+6.9%	$12.2B-4.8%	$12.8B-6.6%	$13.7B
Cost of Revenue	$8.1B	$7.6B+16.1%	$6.5B+0.7%	$6.5B+3.9%	$6.3B+4.8%	$6.0B+14.9%	$5.2B-0.5%	$5.2B-5.2%	$5.5B+3.0%	$5.3B+4.6%	$5.1B-5.8%	$5.4B-3.4%	$5.6B-3.8%	$5.8B-9.5%	$6.5B-7.3%	$7.0B
Gross Profit	$11.3B	$10.1B+10.9%	$9.1B-17.5%	$11.0B-20.0%	$13.8B+11.3%	$12.4B+33.5%	$9.3B+1.1%	$9.2B-10.8%	$10.3B+6.9%	$9.6B+16.4%	$8.3B+9.0%	$7.6B+2.0%	$7.4B+16.7%	$6.4B-0.1%	$6.4B-6.0%	$6.8B
R&D Expenses	$2.1B	$2.1B+6.3%	$2.0B+5.2%	$1.9B+11.6%	$1.7B+7.5%	$1.6B+1.6%	$1.5B-0.9%	$1.5B-1.0%	$1.6B+3.4%	$1.5B+11.2%	$1.4B+7.0%	$1.3B-6.7%	$1.4B-10.8%	$1.5B-18.9%	$1.9B+9.4%	$1.7B
SG&A Expenses	$1.9B	$1.9B+3.7%	$1.8B-1.7%	$1.8B+7.1%	$1.7B+2.3%	$1.7B+2.6%	$1.6B-1.3%	$1.6B-2.3%	$1.7B-0.6%	$1.7B-2.8%	$1.7B+0.8%	$1.7B-6.2%	$1.8B-0.8%	$1.9B+3.0%	$1.8B+10.1%	$1.6B
Operating Income	$7.3B	$6.0B+10.2%	$5.5B-25.5%	$7.3B-27.7%	$10.1B+13.2%	$9.0B+52.0%	$5.9B+3.0%	$5.7B-14.7%	$6.7B+10.4%	$6.1B+25.3%	$4.9B+12.3%	$4.3B+9.5%	$3.9B+39.4%	$2.8B+43.5%	$2.0B-34.1%	$3.0B
EBITDA	N/A	$7.9B+13.9%	$7.0B-18.0%	$8.5B-23.1%	$11.1B+12.3%	$9.9B+44.4%	$6.8B+1.6%	$6.7B-11.8%	$7.6B+9.8%	$6.9B+20.1%	$5.8B+6.9%	$5.4B+5.6%	$5.1B+26.5%	$4.0B+23.7%	$3.3B-18.3%	$4.0B
Interest Expense	$564.0M	$543.0M+6.9%	$508.0M+43.9%	$353.0M+65.0%	$214.0M+16.3%	$184.0M-3.2%	$190.0M+11.8%	$170.0M+36.0%	$125.0M+60.3%	$78.0M-2.5%	$80.0M-11.1%	$90.0M-4.3%	$94.0M-1.1%	$95.0M+11.8%	$85.0M+102.4%	$42.0M
Income Tax	$856.0M	$709.0M+8.4%	$654.0M-28.0%	$908.0M-29.2%	$1.3B+11.6%	$1.1B+172.5%	$422.0M-40.6%	$711.0M-35.7%	$1.1B-53.9%	$2.4B+79.6%	$1.3B+8.5%	$1.2B+16.8%	$1.1B+77.9%	$592.0M+236.4%	$176.0M-75.5%	$719.0M
Net Income	$6.1B	$5.0B+4.2%	$4.8B-26.3%	$6.5B-25.6%	$8.7B+12.6%	$7.8B+38.9%	$5.6B+11.5%	$5.0B-10.1%	$5.6B+51.5%	$3.7B+2.4%	$3.6B+20.4%	$3.0B+5.8%	$2.8B+30.5%	$2.2B+22.9%	$1.8B-21.3%	$2.2B
EPS (Basic)	N/A	$5.47+4.4%	$5.24-26.5%	$7.13-25.0%	$9.51+13.5%	$8.38+38.5%	$6.05+13.5%	$5.33-6.7%	$5.71+55.2%	$3.68+4.0%	$3.54+23.8%	$2.86+9.6%	$2.61+34.5%	$1.94+26.8%	$1.53-19.9%	$1.91
EPS (Diluted)	$6.57	$5.45+4.8%	$5.20-26.4%	$7.07-24.9%	$9.41+13.9%	$8.26+38.4%	$5.97+13.9%	$5.24-6.3%	$5.59+54.8%	$3.61+3.7%	$3.48+23.4%	$2.82+9.7%	$2.57+34.6%	$1.91+26.5%	$1.51-19.7%	$1.88
Diluted Shares (Avg)	N/A	913M-0.7%	919M+0.3%	916M-1.1%	926M-1.1%	936M+0.3%	933M-2.0%	952M-3.8%	990M-2.2%	1.01B-0.9%	1.02B-2.1%	1.04B-3.4%	1.08B-3.0%	1.11B-2.9%	1.15B-2.1%	1.17B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$5.5B+22.8%	$4.8B+18.6%	$4.4B+10.4%	$4.7B+14.2%	$4.4B+16.4%	$4.1B+11.1%	$4.0B-1.7%	$4.2B-8.4%
Cost of Revenue	$2.1B+12.7%	$2.0B+15.4%	$2.0B+15.2%	$2.0B+20.4%	$1.9B+16.3%	$1.8B+12.1%	$1.7B+2.9%	$1.7B-2.3%
Gross Profit	$3.4B+30.2%	$2.8B+21.0%	$2.5B+6.8%	$2.7B+10.1%	$2.6B+16.5%	$2.3B+10.4%	$2.3B-4.8%	$2.5B-12.1%
R&D Expenses	$535.0M+1.5%	$510.0M-1.4%	$521.0M+6.1%	$518.0M+5.3%	$527.0M+5.8%	$517.0M+8.2%	$491.0M+6.7%	$492.0M+4.5%
SG&A Expenses	$490.0M+1.0%	$464.0M-1.7%	$446.0M0.0%	$457.0M+6.8%	$485.0M+4.3%	$472.0M+3.7%	$446.0M+1.8%	$428.0M-5.3%
Operating Income	$2.3B+47.8%	$1.8B+36.6%	$1.5B+7.0%	$1.7B+7.0%	$1.6B+25.2%	$1.3B+3.0%	$1.4B-10.2%	$1.6B-17.9%
EBITDA	$2.9B+41.2%	$2.3B+34.4%	$2.0B+12.1%	$2.2B+11.5%	$2.0B+25.6%	$1.7B+7.1%	$1.8B-3.3%	$1.9B-11.8%
Interest Expense	$141.0M+6.0%	$141.0M+10.2%	$141.0M+8.5%	$141.0M+7.6%	$133.0M+1.5%	$128.0M+10.3%	$130.0M+32.7%	$131.0M+33.7%
Income Tax	$258.0M+41.0%	$169.0M+74.2%	$209.0M+35.7%	$220.0M+14.6%	$183.0M+52.5%	$97.0M-48.4%	$154.0M-13.0%	$192.0M-9.9%
Net Income	$2.0B+52.9%	$1.5B+31.0%	$1.2B-3.5%	$1.4B+0.1%	$1.3B+14.9%	$1.2B+6.7%	$1.2B-12.1%	$1.4B-20.3%
EPS (Basic)	$2.16+52.1%	$1.69+31.0%	$1.27-3.8%	$1.49+0.7%	$1.42+15.4%	$1.29+6.6%	$1.32-12.0%	$1.48-20.9%
EPS (Diluted)	$2.14+51.8%	$1.68+31.2%	$1.27-3.1%	$1.48+0.7%	$1.41+15.6%	$1.28+6.7%	$1.31-12.1%	$1.47-20.5%
Diluted Shares (Avg)	920M+0.9%	914M-0.2%	N/A	914M-0.7%	912M-0.8%	916M-0.1%	N/A	920M+0.4%

TXN Balance Sheet

TXN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$34.6B-2.6%	$35.5B+9.8%	$32.3B+18.9%	$27.2B+10.3%	$24.7B+27.5%	$19.4B+7.4%	$18.0B+5.1%	$17.1B-2.9%	$17.6B+7.4%	$16.4B+1.2%	$16.2B-6.6%	$17.4B-8.3%	$18.9B-5.4%	$20.0B-2.3%	$20.5B
Current Assets	$13.8B-8.5%	$15.0B-0.6%	$15.1B+7.9%	$14.0B+2.5%	$13.7B+33.7%	$10.2B+16.9%	$8.8B+8.2%	$8.1B-7.3%	$8.7B+17.1%	$7.5B+5.4%	$7.1B-4.7%	$7.4B-7.5%	$8.0B-2.6%	$8.2B+5.1%	$7.8B
Cash & Equivalents	$3.2B+0.8%	$3.2B+8.0%	$3.0B-2.8%	$3.0B-34.1%	$4.6B+49.1%	$3.1B+27.5%	$2.4B0.0%	$2.4B+47.2%	$1.7B+43.5%	$1.2B+15.4%	$1.0B-16.6%	$1.2B-26.3%	$1.6B+14.9%	$1.4B+42.7%	$992.0M
Short-Term Investments	$1.7B-62.2%	$4.4B-21.9%	$5.6B-6.7%	$6.0B+17.8%	$5.1B+47.6%	$3.5B+17.3%	$3.0B+64.3%	$1.8B-36.2%	$2.8B+20.4%	$2.3B+5.3%	$2.2B-5.3%	$2.3B+6.4%	$2.2B-13.6%	$2.5B+31.2%	$1.9B
Inventory	$4.8B+6.1%	$4.5B+13.2%	$4.0B+45.0%	$2.8B+44.3%	$1.9B-2.3%	$2.0B-2.3%	$2.0B-9.7%	$2.2B+13.3%	$2.0B+9.3%	$1.8B+5.9%	$1.7B-5.2%	$1.8B+3.1%	$1.7B-1.5%	$1.8B-1.7%	$1.8B
Accounts Receivable	$2.0B+14.2%	$1.7B-3.8%	$1.8B-5.7%	$1.9B+11.4%	$1.7B+20.3%	$1.4B+31.7%	$1.1B-11.0%	$1.2B-5.6%	$1.3B+0.9%	$1.3B+8.8%	$1.2B-6.5%	$1.2B+3.6%	$1.2B-2.2%	$1.2B-20.4%	$1.5B
Long-Term Investments	$16.0M-30.4%	$23.0M-32.4%	$34.0M0.0%	$34.0M-45.2%	$62.0M+26.5%	$49.0M-83.7%	$300.0M+19.5%	$251.0M-6.3%	$268.0M+14.0%	$235.0M+6.3%	$221.0M-1.3%	$224.0M+3.7%	$216.0M+0.5%	$215.0M-18.9%	$265.0M
Goodwill	$4.3B-0.7%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B-2.0%	$4.5B
Total Liabilities	$18.3B-1.6%	$18.6B+20.4%	$15.5B+22.3%	$12.6B+11.3%	$11.3B+11.6%	$10.2B+11.6%	$9.1B+11.9%	$8.1B+11.5%	$7.3B+22.6%	$6.0B-5.2%	$6.3B-10.0%	$7.0B-14.1%	$8.1B-10.3%	$9.1B-5.1%	$9.5B
Current Liabilities	$3.2B-13.3%	$3.6B+9.7%	$3.3B+11.2%	$3.0B+16.2%	$2.6B+7.5%	$2.4B+12.6%	$2.1B-14.2%	$2.5B+9.6%	$2.3B-0.3%	$2.3B-11.4%	$2.6B-3.9%	$2.7B-3.2%	$2.7B-19.9%	$3.4B-2.0%	$3.5B
Non-Current Liabilities	$15.2B+1.3%	$15.0B+23.3%	$12.1B+25.8%	$9.6B+9.9%	$8.8B+12.9%	$7.8B+11.2%	$7.0B+23.3%	$5.7B+12.3%	$5.0B+36.6%	$3.7B-0.9%	$3.7B-13.8%	$4.3B-19.7%	$5.4B-4.4%	$5.6B-6.9%	$6.0B
Long-Term Debt	$13.5B+5.5%	$12.8B+20.9%	$10.6B+29.0%	$8.2B+13.7%	$7.2B+15.9%	$6.2B+17.8%	$5.3B+22.8%	$4.3B+20.7%	$3.6B+20.1%	$3.0B-4.6%	$3.1B-14.0%	$3.6B-12.7%	$4.2B-0.7%	$4.2B-0.6%	$4.2B
Total Equity	$16.3B-3.7%	$16.9B0.0%	$16.9B+15.9%	$14.6B+9.3%	$13.3B+45.1%	$9.2B+3.1%	$8.9B-1.0%	$9.0B-13.0%	$10.3B-1.3%	$10.5B+5.3%	$9.9B-4.3%	$10.4B-3.9%	$10.8B-1.4%	$11.0B+0.1%	$11.0B
Retained Earnings	$52.2B0.0%	$52.3B0.0%	$52.3B+3.8%	$50.4B+9.7%	$45.9B+9.2%	$42.1B+5.4%	$39.9B+5.3%	$37.9B+9.4%	$34.7B+4.7%	$33.1B+6.2%	$31.2B+5.1%	$29.7B+5.3%	$28.2B+3.6%	$27.2B+3.5%	$26.3B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$35.9B+2.7%	$34.4B+1.9%	$34.6B-2.6%	$35.0B-0.9%	$34.9B-0.3%	$33.8B-3.2%	$35.5B+9.8%	$35.3B+11.6%
Current Assets	$15.8B+8.8%	$13.8B+5.4%	$13.8B-8.5%	$13.9B-12.6%	$14.5B-13.7%	$13.1B-25.0%	$15.0B-0.6%	$15.9B+5.1%
Cash & Equivalents	$3.7B+20.2%	$3.5B+28.4%	$3.2B+0.8%	$3.3B+27.9%	$3.0B+11.1%	$2.8B+11.3%	$3.2B+8.0%	$2.6B+0.9%
Short-Term Investments	$3.3B+44.3%	$1.6B-30.7%	$1.7B-62.2%	$1.9B-69.6%	$2.3B-66.7%	$2.2B-71.7%	$4.4B-21.9%	$6.2B-3.4%
Inventory	$4.6B-4.3%	$4.7B+0.2%	$4.8B+6.1%	$4.8B+12.4%	$4.8B+17.2%	$4.7B+14.8%	$4.5B+13.2%	$4.3B+9.9%
Accounts Receivable	$2.5B+30.3%	$2.2B+20.7%	$2.0B+14.2%	$2.1B+10.7%	$1.9B+13.0%	$1.9B+11.3%	$1.7B-3.8%	$1.9B-5.8%
Long-Term Investments	$15.0M-11.8%	$15.0M-25.0%	$16.0M-30.4%	$17.0M-34.6%	$17.0M-37.0%	$20.0M-28.6%	$23.0M-32.4%	$26.0M-18.8%
Goodwill	$4.3B-0.7%	$4.3B-0.7%	$4.3B-0.7%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%	$4.4B0.0%
Total Liabilities	$17.9B-3.5%	$17.6B+1.5%	$18.3B-1.6%	$18.4B+1.8%	$18.5B+3.9%	$17.4B-3.1%	$18.6B+20.4%	$18.1B+20.3%
Current Liabilities	$3.2B+30.2%	$3.1B+24.4%	$3.2B-13.3%	$3.1B-15.4%	$2.5B-31.5%	$2.5B-29.9%	$3.6B+9.7%	$3.7B+39.0%
Non-Current Liabilities	$14.6B-8.8%	$14.5B-2.3%	$15.2B+1.3%	$15.3B+6.2%	$16.0B+13.0%	$14.9B+3.6%	$15.0B+23.3%	$14.4B+16.3%
Long-Term Debt	$12.9B-8.1%	$12.9B+0.4%	$13.5B+5.5%	$13.5B+5.5%	$14.0B+9.4%	$12.8B+0.1%	$12.8B+20.9%	$12.8B+17.6%
Total Equity	$18.0B+9.8%	$16.8B+2.3%	$16.3B-3.7%	$16.6B-3.7%	$16.4B-4.7%	$16.4B-3.4%	$16.9B0.0%	$17.3B+3.8%
Retained Earnings	$53.2B+1.7%	$52.5B+0.5%	$52.2B0.0%	$52.4B+0.1%	$52.2B+0.2%	$52.2B0.0%	$52.3B0.0%	$52.3B+0.4%

TXN Cash Flow Statement

TXN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$8.7B	$7.2B+13.2%	$6.3B-1.6%	$6.4B-26.4%	$8.7B-0.4%	$8.8B+42.6%	$6.1B-7.7%	$6.6B-7.5%	$7.2B+34.0%	$5.4B+16.2%	$4.6B+4.9%	$4.4B+8.5%	$4.1B+19.8%	$3.4B-0.9%	$3.4B+4.9%	$3.3B
Depreciation & Amortization	N/A	$1.9B+27.2%	$1.5B+28.3%	$1.2B+27.0%	$925.0M+3.1%	$897.0M-3.7%	$931.0M-6.5%	$996.0M+9.7%	$908.0M+6.0%	$857.0M-7.3%	$924.0M-14.8%	$1.1B-7.3%	$1.2B-3.6%	$1.2B-6.5%	$1.3B+28.0%	$1.0B
Stock-Based Compensation	N/A	$419.0M+8.3%	$387.0M+6.9%	$362.0M+25.3%	$289.0M+25.7%	$230.0M+2.7%	$224.0M+3.2%	$217.0M-6.5%	$232.0M-4.1%	$242.0M-4.0%	$252.0M-11.9%	$286.0M+3.2%	$277.0M-3.5%	$287.0M+9.1%	$263.0M-2.2%	$269.0M
Capital Expenditures	$3.3B	$4.5B-5.6%	$4.8B-4.9%	$5.1B+81.3%	$2.8B+13.6%	$2.5B+279.4%	$649.0M-23.4%	$847.0M-25.1%	$1.1B+62.7%	$695.0M+30.9%	$531.0M-3.6%	$551.0M+43.1%	$385.0M-6.6%	$412.0M-16.8%	$495.0M-39.3%	$816.0M
Free Cash Flow	$5.4B	$2.6B+73.8%	$1.5B+11.0%	$1.3B-77.2%	$5.9B-5.9%	$6.3B+14.6%	$5.5B-5.4%	$5.8B-4.2%	$6.1B+29.8%	$4.7B+14.3%	$4.1B+6.2%	$3.8B+4.8%	$3.7B+23.5%	$3.0B+1.8%	$2.9B+19.6%	$2.4B
Investing Cash Flow	-$3.1B	-$1.4B+55.1%	-$3.2B+26.6%	-$4.4B-21.7%	-$3.6B+12.5%	-$4.1B-344.1%	-$922.0M+52.0%	-$1.9B-2361.5%	-$78.0M+93.1%	-$1.1B-73.4%	-$650.0M	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$4.9B	-$5.7B-97.5%	-$2.9B-34.3%	-$2.1B+68.1%	-$6.7B-114.2%	-$3.1B+31.0%	-$4.5B+3.9%	-$4.7B+25.3%	-$6.3B-69.5%	-$3.7B+2.0%	-$3.8B	N/A	N/A	N/A	N/A	N/A
Dividends Paid	$5.1B	$5.0B+4.3%	$4.8B+5.2%	$4.6B+6.1%	$4.3B+10.6%	$3.9B+13.4%	$3.4B+13.9%	$3.0B+17.7%	$2.6B+21.4%	$2.1B+27.8%	$1.6B+14.0%	$1.4B+9.1%	$1.3B+12.6%	$1.2B+43.5%	$819.0M+27.2%	$644.0M
Share Buybacks	$707.0M	$1.5B+59.0%	$929.0M+217.1%	$293.0M-91.9%	$3.6B+586.0%	$527.0M-79.4%	$2.6B-13.8%	$3.0B-42.0%	$5.1B+99.5%	$2.6B+19.9%	$2.1B-22.2%	$2.7B-3.2%	$2.8B-1.3%	$2.9B+59.3%	$1.8B-8.8%	$2.0B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$2.7B+45.3%	$1.5B+79.0%	$2.3B+12.8%	$2.2B+26.4%	$1.9B+18.4%	$849.0M-16.5%	$2.0B+3.8%	$1.7B-10.6%
Depreciation & Amortization	$547.0M+18.9%	$541.0M+27.6%	$537.0M+29.1%	$497.0M+29.8%	$460.0M+26.7%	$424.0M+22.5%	$416.0M+29.2%	$383.0M+26.4%
Stock-Based Compensation	N/A	$109.0M-6.0%	N/A	N/A	N/A	$116.0M+9.4%	N/A	N/A
Capital Expenditures	$514.0M-60.6%	$676.0M-39.8%	$925.0M-22.4%	$1.2B-9.0%	$1.3B+22.7%	$1.1B-10.0%	$1.2B+3.8%	$1.3B-12.0%
Free Cash Flow	$2.2B+294.4%	$844.0M+408.0%	$1.3B+64.9%	$993.0M+138.7%	$555.0M+9.5%	-$274.0M-18.6%	$806.0M+3.9%	$416.0M-5.9%
Investing Cash Flow	-$1.7B-27.5%	-$47.0M-103.8%	-$676.0M-210.1%	-$681.0M-39.8%	-$1.3B	$1.3B+137.6%	$614.0M+297.4%	-$487.0M+71.3%
Financing Cash Flow	-$890.0M-264.8%	-$1.1B+54.7%	-$1.7B+16.8%	-$1.2B+11.0%	-$244.0M+81.4%	-$2.5B-238.7%	-$2.0B-64.7%	-$1.4B-25.1%
Dividends Paid	$1.3B+4.9%	$1.3B+4.3%	$1.3B+4.0%	$1.2B+4.1%	$1.2B+4.2%	$1.2B+4.6%	$1.2B+5.0%	$1.2B+5.4%
Share Buybacks	$27.0M-91.1%	$158.0M-75.8%	$403.0M-25.0%	$119.0M-62.6%	$302.0M+325.4%	$653.0M+21666.7%	$537.0M+726.2%	$318.0M+591.3%

TXN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TXN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	57.0%-1.1pp	58.1%-4.8pp	62.9%-5.9pp	68.8%+1.3pp	67.5%+3.4pp	64.1%+0.4pp	63.7%-1.4pp	65.1%+0.9pp	64.3%+2.5pp	61.8%+3.5pp	58.3%+1.3pp	56.9%+4.8pp	52.1%+2.5pp	49.6%+0.4pp	49.3%
Operating Margin	34.1%-0.9pp	34.9%-6.9pp	41.9%-8.8pp	50.6%+1.8pp	48.8%+8.1pp	40.8%+1.0pp	39.8%-2.7pp	42.5%+1.9pp	40.7%+4.4pp	36.3%+3.1pp	33.3%+3.0pp	30.3%+7.1pp	23.2%+7.8pp	15.4%-6.4pp	21.8%
Net Margin	28.3%-2.4pp	30.7%-6.5pp	37.2%-6.5pp	43.7%+1.3pp	42.4%+3.7pp	38.7%+3.8pp	34.9%-0.5pp	35.4%+10.7pp	24.6%-2.3pp	26.9%+3.9pp	23.0%+1.3pp	21.6%+3.9pp	17.7%+4.0pp	13.7%-2.6pp	16.3%
Return on Equity	30.7%+2.3pp	28.4%-10.1pp	38.5%-21.5pp	60.0%+1.7pp	58.3%-2.6pp	60.9%+4.6pp	56.3%-5.7pp	62.0%+26.4pp	35.6%+1.3pp	34.3%+4.3pp	30.0%+2.9pp	27.2%+7.1pp	20.0%+4.0pp	16.1%-4.4pp	20.4%
Return on Assets	14.5%+1.0pp	13.5%-6.6pp	20.1%-12.0pp	32.2%+0.7pp	31.5%+2.6pp	28.9%+1.1pp	27.8%-4.7pp	32.6%+11.7pp	20.9%-1.0pp	21.9%+3.5pp	18.4%+2.2pp	16.2%+4.8pp	11.4%+2.6pp	8.8%-2.1pp	10.9%
Current Ratio	4.35+0.2x	4.12-0.4x	4.55-0.1x	4.70-0.6x	5.33+1.0x	4.28+0.2x	4.13+0.9x	3.27-0.6x	3.87+0.6x	3.29+0.5x	2.770.0x	2.79-0.1x	2.92+0.5x	2.40+0.2x	2.24
Debt-to-Equity	0.83+0.1x	0.76+0.1x	0.63+0.1x	0.560.0x	0.54-0.1x	0.68+0.1x	0.60+0.1x	0.48+0.1x	0.35+0.1x	0.280.0x	0.310.0x	0.350.0x	0.380.0x	0.380.0x	0.38
Asset Turnover	0.51+0.1x	0.44-0.1x	0.54-0.2x	0.740.0x	0.740.0x	0.75-0.1x	0.80-0.1x	0.92+0.1x	0.850.0x	0.810.0x	0.80+0.1x	0.75+0.1x	0.640.0x	0.640.0x	0.67
FCF Margin	14.7%+5.1pp	9.6%+1.9pp	7.7%-21.9pp	29.6%-4.7pp	34.3%-3.6pp	38.0%-2.4pp	40.3%+2.0pp	38.4%+7.2pp	31.2%+0.7pp	30.5%+1.0pp	29.6%+1.5pp	28.1%+3.8pp	24.3%+1.6pp	22.8%+5.0pp	17.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	61.4%+3.5pp	58.0%+1.2pp	55.9%-1.9pp	57.4%-2.2pp	57.9%0.0pp	56.8%-0.4pp	57.8%-1.9pp	59.6%-2.5pp
Operating Margin	42.3%+7.1pp	37.5%+4.9pp	33.3%-1.1pp	35.1%-2.4pp	35.1%+2.5pp	32.5%-2.6pp	34.4%-3.2pp	37.4%-4.3pp
Net Margin	36.2%+7.1pp	32.0%+3.0pp	26.3%-3.8pp	28.8%-4.0pp	29.1%-0.4pp	29.0%-1.2pp	30.1%-3.6pp	32.8%-4.9pp
Return on Equity	11.0%+3.1pp	9.2%+2.0pp	7.1%0.0pp	8.2%+0.3pp	7.9%+1.3pp	7.2%+0.7pp	7.1%-1.0pp	7.9%-2.4pp
Return on Assets	5.5%+1.8pp	4.5%+1.0pp	3.4%0.0pp	3.9%0.0pp	3.7%+0.5pp	3.5%+0.3pp	3.4%-0.9pp	3.9%-1.5pp
Current Ratio	4.86-1.0x	4.46-0.8x	4.35+0.2x	4.45+0.1x	5.81+1.2x	5.26+0.3x	4.12-0.4x	4.31-1.4x
Debt-to-Equity	0.72-0.1x	0.770.0x	0.83+0.1x	0.81+0.1x	0.86+0.1x	0.780.0x	0.76+0.1x	0.74+0.1x
Asset Turnover	0.150.0x	0.140.0x	0.130.0x	0.140.0x	0.130.0x	0.120.0x	0.110.0x	0.120.0x
FCF Margin	40.1%+27.6pp	17.5%+24.2pp	30.0%+9.9pp	20.9%+10.9pp	12.5%-0.8pp	-6.7%-0.4pp	20.1%+1.1pp	10.0%+0.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Texas Instruments Incorporated TXN	FY2025	$17.7B	$5.0B	28.3%	$268.3B	68/100
Qualcomm Inc QCOM	FY2025	$44.3B	$5.5B	12.5%	$197.5B	78/100
Micron Technology, Inc. MU	FY2025	$37.4B	$8.5B	22.8%	$1.2T	57/100
Arm Holdings ARM	FY2026	$4.9B	$904.0M	18.4%	$328.4B	77/100
Analog Devices, Inc. ADI	FY2025	$11.0B	$2.3B	20.6%	$202.1B	61/100
Intel Corp INTC	FY2025	$52.9B	-$267.0M	-0.5%	$630.8B	25/100

Where Texas Instruments Incorporated Ranks

Frequently Asked Questions

What is Texas Instruments Incorporated's annual revenue?

Texas Instruments Incorporated (TXN) reported $17.7B in total revenue for fiscal year 2025. This represents a 13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Texas Instruments Incorporated's revenue growing?

Texas Instruments Incorporated (TXN) revenue grew by 13.0% year-over-year, from $15.6B to $17.7B in fiscal year 2025.

Is Texas Instruments Incorporated profitable?

Yes, Texas Instruments Incorporated (TXN) reported a net income of $5.0B in fiscal year 2025, with a net profit margin of 28.3%.

What is Texas Instruments Incorporated's EBITDA?

Texas Instruments Incorporated (TXN) had EBITDA of $7.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Texas Instruments Incorporated have?

As of fiscal year 2025, Texas Instruments Incorporated (TXN) had $3.2B in cash and equivalents against $13.5B in long-term debt.

What is Texas Instruments Incorporated's gross margin?

Texas Instruments Incorporated (TXN) had a gross margin of 57.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Texas Instruments Incorporated's operating margin?

Texas Instruments Incorporated (TXN) had an operating margin of 34.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Texas Instruments Incorporated's net profit margin?

Texas Instruments Incorporated (TXN) had a net profit margin of 28.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Texas Instruments Incorporated pay dividends?

Yes, Texas Instruments Incorporated (TXN) paid $5.50 per share in dividends during fiscal year 2025.

What is Texas Instruments Incorporated's return on equity (ROE)?

Texas Instruments Incorporated (TXN) has a return on equity of 30.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Texas Instruments Incorporated's free cash flow?

Texas Instruments Incorporated (TXN) generated $2.6B in free cash flow during fiscal year 2025. This represents a 73.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Texas Instruments Incorporated's operating cash flow?

Texas Instruments Incorporated (TXN) generated $7.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Texas Instruments Incorporated's total assets?

Texas Instruments Incorporated (TXN) had $34.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Texas Instruments Incorporated's capital expenditures?

Texas Instruments Incorporated (TXN) invested $4.5B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Texas Instruments Incorporated spend on research and development?

Texas Instruments Incorporated (TXN) invested $2.1B in research and development during fiscal year 2025.

Does Texas Instruments Incorporated buy back shares?

Yes, Texas Instruments Incorporated (TXN) spent $1.5B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Texas Instruments Incorporated have outstanding?

Texas Instruments Incorporated (TXN) had 908M shares outstanding as of fiscal year 2025.

What is Texas Instruments Incorporated's current ratio?

Texas Instruments Incorporated (TXN) had a current ratio of 4.35 as of fiscal year 2025, which is generally considered healthy.

What is Texas Instruments Incorporated's debt-to-equity ratio?

Texas Instruments Incorporated (TXN) had a debt-to-equity ratio of 0.83 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Texas Instruments Incorporated's return on assets (ROA)?

Texas Instruments Incorporated (TXN) had a return on assets of 14.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Texas Instruments Incorporated's P/E ratio?

Texas Instruments Incorporated (TXN) trades at 44.3x earnings, its market capitalization divided by net income of $6.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $268.3B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Texas Instruments Incorporated's price-to-sales ratio?

Texas Instruments Incorporated (TXN) trades at 13.8x sales, its market capitalization divided by revenue of $19.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $268.3B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Texas Instruments Incorporated's Altman Z-Score?

Texas Instruments Incorporated (TXN) has an Altman Z-Score of 12.36, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Texas Instruments Incorporated's Piotroski F-Score?

Texas Instruments Incorporated (TXN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Texas Instruments Incorporated's earnings high quality?

Texas Instruments Incorporated (TXN) has an earnings quality ratio of 1.43x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Texas Instruments Incorporated cover its interest payments?

Texas Instruments Incorporated (TXN) has an interest coverage ratio of 11.09x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Texas Instruments Incorporated?

Texas Instruments Incorporated (TXN) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.